申请人:Bristol-Myers Company
公开号:US04668687A1
公开(公告)日:1987-05-26
A series of nootropic compounds of the following formula: ##STR1## and its pharmaceutically acceptable acid addition salts, wherein: R.sup.2 is hydrogen, lower alkyl, aryl which is optimally substituted, or hetaryl; R.sup.7 is hydrogen or is combined with R.sup.9 as a fused benzo-ring; R.sup.8 is hydrogen or lower alkyl; and R.sup.9 is lower alkyl, or R.sup.9 can be combined with R.sup.8 to give a 2-pyrrolidinone, a phthalimide, or isoindolone ring system. Pharmacological testing demonstrates that the series possesses cognition and memory enhancing actions and/or mild CNS simulation.
以下是该化合物系列的一系列脑功能增强化合物的中文翻译:##STR1##及其药学上可接受的酸盐,其中:R.sup.2为氢、较低的烷基、最佳取代的芳基或杂环基;R.sup.7为氢或与R.sup.9结合成融合苯环;R.sup.8为氢或较低的烷基;R.sup.9为较低的烷基,或R.sup.9可以与R.sup.8结合形成2-吡咯烷酮、邻苯二甲酰亚胺或异吲哚酮环系统。药理学测试表明该系列具有增强认知和记忆功能以及/或轻度中枢神经系统刺激作用。